RecruitingObservationalLast updated Mar 14, 2025

Study on the Diagnosis and Management of CLL in Italy by GIMEMA

Observational Study on the Diagnosis and Management of Chronic Lymphocytic Leukemia (CLL) in Italy by Gruppo Italiano Malattie EMatologiche Dell'Adulto (GIMEMA)

Overview

ClinicalTrials.gov ID: NCT04867915
Lead Sponsor: Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER
Brief Summary: retrospective and prospective multicenter observational clinical and biological data collection from all patients with newly diagnosed CLL, SLL or MBL.

retrospective cohort: all cases with a diagnosis between January 1st 2010 and August 31th 2021.

prospective cohort: all patients with a diagnosis between September 1st 2021 and September 1st 2025.
Study Type

Status

Overall Status: Recruiting
Start Date: Oct 13, 2021Actual
Primary Completion Date: Oct 2026Estimated
Completion Date: Oct 2026Estimated

Study Record Dates

First Submitted: Apr 28, 2021
First Submitted that Met QC Criteria: Apr 29, 2021
First Posted: Apr 30, 2021Actual
Last Update Submitted that Met QC Criteria: Mar 12, 2025
Last Update Posted: Mar 14, 2025Actual
Last Verified: Mar 2025

NCT04070807Unknown status

Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2

NCT04627090Unknown status

LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study

NCT05803395Unknown status

Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.

NCT04282811Active, not recruiting

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

NCT01699217Completed

Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

NCT06008691Recruiting

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice